Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc NRIFF


Primary Symbol: MRVFF

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Bullboard Posts
Comment by Montrose2on Feb 19, 2009 5:56pm
405 Views
Post# 15791014

RE: RE: Annual Report and AGM

RE: RE: Annual Report and AGM Well I am a long time holder of this issue although recent enough that my average price is not significantly higher than where we are now.  I neither smile nor frown at the prospect of a consolidation but rather view myself as someone who had endured similar situations in the past and suspect that the company will move to propose just that type of action.

Whatever their next decision may be it is evident that things are now moving along rather smartly.  I admit that I was impressed that they beat their "within 60 days" FDA submission by a large margin.   Having crossed this latest hurdle they can likely get into more serious negotiations with larger companies needing only to add the "completion of FDA approval" clause.

Onward and Upward.
Bullboard Posts